BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Long MD, Hutfless S, Kappelman MD, Khalili H, Kaplan GG, Bernstein CN, Colombel JF, Gower-Rousseau C, Herrinton L, Velayos F, Loftus EV Jr, Nguyen GC, Ananthakrishnan AN, Sonnenberg A, Chan A, Sandler RS, Atreja A, Shah SA, Rothman KJ, Leleiko NS, Bright R, Boffetta P, Myers KD, Sands BE. Challenges in designing a national surveillance program for inflammatory bowel disease in the United States. Inflamm Bowel Dis 2014;20:398-415. [PMID: 24280882 DOI: 10.1097/01.MIB.0000435441.30107.8b] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Cheng Y, Mclean R, Sewell JL, Huang C, Khalili M. Inflammatory bowel disease type influences development of elevated liver enzymes. JGH Open 2022. [DOI: 10.1002/jgh3.12831] [Reference Citation Analysis]
2 Barnes EL, Allin KH, Iversen AT, Herfarth HH, Jess T. Increasing Incidence of Pouchitis between 1996 and 2018: A Population-Based Danish Cohort Study. Clin Gastroenterol Hepatol 2022:S1542-3565(22)00440-2. [PMID: 35525393 DOI: 10.1016/j.cgh.2022.04.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
3 Bets VD, Achasova KM, Borisova MA, Kozhevnikova EN, Litvinova EA. Role of Mucin 2 Glycoprotein and L-Fucose in Interaction of Immunity and Microbiome within the Experimental Model of Inflammatory Bowel Disease. Biochemistry (Mosc) 2022;87:301-18. [PMID: 35527372 DOI: 10.1134/S0006297922040010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Cowherd E, Egberg MD, Kappelman MD, Zhang X, Long MD, Lightner AL, Sandler RS, Herfarth HH, Barnes EL. The Cumulative Incidence of Pouchitis in Pediatric Patients With Ulcerative Colitis. Inflamm Bowel Dis 2022:izab320. [PMID: 35040995 DOI: 10.1093/ibd/izab320] [Reference Citation Analysis]
5 Sánta A, Lucza L, Rafael B. Alkalmazott egészségpszichológia a belgyógyászati ellátásban. Pszichológusok a betegellátásban 2022. [DOI: 10.14232/sztep.pszibet.2022.2] [Reference Citation Analysis]
6 Barnes EL, Kappelman MD, Zhang X, Long MD, Sandler RS, Herfarth HH. Patients With Pouchitis Demonstrate a Significant Cost Burden in the First Two Years After Ileal Pouch-Anal Anastomosis. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01052-1. [PMID: 34610443 DOI: 10.1016/j.cgh.2021.09.037] [Reference Citation Analysis]
7 de Laffolie J. Epidemiologische Forschung und Behandlungsdatenanalyse zu chronisch-entzündlichen Darmerkrankungen: Verbesserung der Versorgung von Kindern und Jugendlichen. Monatsschr Kinderheilkd 2020;168:298-313. [DOI: 10.1007/s00112-020-00852-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Hemperly A, Vande Casteele N. Clinical Pharmacokinetics and Pharmacodynamics of Infliximab in the Treatment of Inflammatory Bowel Disease. Clin Pharmacokinet 2018;57:929-42. [PMID: 29330783 DOI: 10.1007/s40262-017-0627-0] [Cited by in Crossref: 62] [Cited by in F6Publishing: 68] [Article Influence: 20.7] [Reference Citation Analysis]
9 Ma J, Yang Y, Fu Y, Guo F, Zhang X, Xiao S, Zhu W, Huang Z, Zhang J, Chen J. PIAS3-mediated feedback loops promote chronic colitis-associated malignant transformation. Theranostics 2018;8:3022-37. [PMID: 29896300 DOI: 10.7150/thno.23046] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
10 Barnes EL, Kochar B, Long MD, Kappelman MD, Martin CF, Korzenik JR, Crockett SD. Modifiable Risk Factors for Hospital Readmission Among Patients with Inflammatory Bowel Disease in a Nationwide Database. Inflamm Bowel Dis 2017;23:875-81. [PMID: 28426473 DOI: 10.1097/MIB.0000000000001121] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 13.5] [Reference Citation Analysis]
11 Xu F, Dahlhamer JM, Zammitti EP, Wheaton AG, Croft JB. Health-Risk Behaviors and Chronic Conditions Among Adults with Inflammatory Bowel Disease - United States, 2015 and 2016. MMWR Morb Mortal Wkly Rep. 2018;67:190-195. [PMID: 29447146 DOI: 10.15585/mmwr.mm6706a4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
12 Malarcher CA, Wheaton AG, Liu Y, Greenlund SF, Greenlund SJ, Lu H, Croft JB. Hospitalizations for Crohn's Disease - United States, 2003-2013. MMWR Morb Mortal Wkly Rep 2017;66:377-81. [PMID: 28406887 DOI: 10.15585/mmwr.mm6614a1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
13 Li Y, Su X, Wu P, Wang J, Guo Y, Zhu J, Wang Q, Chen J, Yang F, Wei W. Proteomics analysis of IBS-D with spleen and kidney yang deficiency. Journal of Traditional Chinese Medical Sciences 2017;4:39-49. [DOI: 10.1016/j.jtcms.2017.05.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
14 Cunningham KE, Vincent G, Sodhi CP, Novak EA, Ranganathan S, Egan CE, Stolz DB, Rogers MB, Firek B, Morowitz MJ, Gittes GK, Zuckerbraun BS, Hackam DJ, Mollen KP. Peroxisome Proliferator-activated Receptor-γ Coactivator 1-α (PGC1α) Protects against Experimental Murine Colitis. J Biol Chem 2016;291:10184-200. [PMID: 26969166 DOI: 10.1074/jbc.M115.688812] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 7.5] [Reference Citation Analysis]
15 Cherry LN, Yunker NS, Lambert ER, Vaughan D, Lowe DK. Vedolizumab: an α4β7 integrin antagonist for ulcerative colitis and Crohn's disease. Ther Adv Chronic Dis 2015;6:224-33. [PMID: 26336591 DOI: 10.1177/2040622315586970] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
16 Whitfield EP, Fredericks EM, Eder SJ, Shpeen BH, Adler J. Transition readiness in pediatric patients with inflammatory bowel disease: patient survey of self-management skills. J Pediatr Gastroenterol Nutr. 2015;60:36-41. [PMID: 25199036 DOI: 10.1097/mpg.0000000000000555] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 5.4] [Reference Citation Analysis]
17 Parlato M, Yeretssian G. NOD-like receptors in intestinal homeostasis and epithelial tissue repair. Int J Mol Sci. 2014;15:9594-9627. [PMID: 24886810 DOI: 10.3390/ijms15069594] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 6.6] [Reference Citation Analysis]
18 Ananthakrishnan AN, Chan AT. Reply. Gastroenterology 2014;146:1134-1135. [DOI: 10.1053/j.gastro.2014.02.035] [Reference Citation Analysis]